A blog about the accuracy of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for detecting dementia, explained with the help of some Lego!
Page last updated 28 April 2022.
In the UK, 9.9 million people are aged over 65 and it has been estimated that around 6.6% have dementia; in the over 85s, this may be as high as 50%. Dementia has been identified as a national priority in health and social care and recent guidelines have emphasized early diagnosis to help with planning and management, though ‘screening’ for dementia remains the subject of debate.
A questionnaire to identify possible dementia
Currently, less than half those with dementia will be diagnosed as having it. There are lots of different ways of assessing people for possible dementia and no clear agreement about the best way to do it. One approach is to ask someone who knows the person about changes they’ve observed and a questionnaire that is commonly used for this purpose is the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE).
A team led by Dr Terry Quinn at the Cochrane Dementia and Cognitive Improvement Group has conducted a series of Cochrane Reviews are systematic reviews. In systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. to find out what research can tell us about the accuracy of the IQCODE, used in different settings, for identifying possible dementia. A diagnosis of dementia can’t be made using the IQCODE alone, but this questionnaire can be used to flag up the need for further assessment or to help with a diagnosis along with other investigations.
Two thirds of adults with dementia live in the community. The Cochrane Review Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations (July 2021), so about assessing adults who had not been selected on the basis of cognitive testing or symptoms, draws on 11 datasets with Data is the information collected through research. from 2644 people. The reviewers looked at the accuracy of the test against expert clinical diagnosis of dementia. The cut-off points for a ‘positive’ test result were those commonly used in clinical practice (3.3 to 3.6).
Here’s what they found:
The reviewers found that although the accuracy of the IQCODE is in a range that many would consider reasonable, in this The group of people being studied. Populations may be defined by any characteristics e.g. where they live, age group, certain diseases. its use is likely to result in a large number of people being wrongly assessed as likely to have dementia and a large number of people who do have dementia being missed.
If 100 older people living in the community are assessed for dementia using the IQCODE….
Six people will be correctly diagnosed as having dementia
One person will have dementia but this will be missed by the test
79 people will not have dementia and will be correctly assessed by the test
But 14 people who do not have dementia will be incorrectly diagnosed as having it
So this is how the 100 have been sorted. It’s wrong for 15 of them.
How many would be wrongly assessed in our UK population?
What else did they find out?
The shorter, 16 item version of the IQCODE, already common in clinical practice, was found to be no more or less accurate than the 26 item version and is quicker to complete. There was little difference in accuracy between the different cut-off points used. The reviewers note that the included studies have limitations and potential biases but also that their results are consistent and the findings of the review reasonably robust.
The review looked at the IQCODE only so cannot assess how it compares to other tests or how well it works used with other tests. The team have also looked at the evidence for the accuracy of the IQCODE in general practice and in hospital settings in separate reviews: Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a general practice (primary care) setting (July 2021) and Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting (July 2021).
How good was the evidence?
In many of the studies there was substantial potential for Any factor, recognised or not, that distorts the findings of a study. For example, reporting bias is a type of bias that occurs when researchers, or others (e.g. drug companies) choose not report or publish the results of a study, or do not provide full information about a study. and the quality of reporting could have been better. On the whole, there was enough detail and the clinical dementia assessment was robust, but methodology and reporting of patient sampling and use of IQCODE could be improved.
Where does that leave us?
Using the IQCODE alone in a general community population would result in a lot of false results.
The reviewers conclude:
“As a single assessment tool IQCODE properties may not be suited to population level screening… Given the public perception of dementia, it is arguable that the distress caused by assigning a dementia label to a person without the disease is greater than the potential harm of initially missing dementia on screening. These are important concepts that need to be considered if large scale cognitive screening is to be introduced.”
More blogs about diagnosing dementia
Many thanks to Dr Terry Quinn, University of Glasgow, for helping us explain the results using Lego!
Please note, we cannot give specific medical advice and do not publish comments that link to individual pages requesting donations or to commercial sites, or appear to endorse commercial products. We welcome diverse views and encourage discussion but we ask that comments are respectful and reserve the right to not publish any we consider offensive. Cochrane UK does not fact check – or endorse – readers’ comments, including any treatments mentioned.
Sarah has nothing to disclose.